Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Good Girl Rx vs Ravia Health

Good Girl Rx
Graded #277

Higher grade

vs+2.8999999999999986
Ravia Health
Graded #347

Lower grade

The verdict

Good Girl Rx takes it — 62.1/100 to 59.2/100.

Good Girl Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Good Girl Rx (Good Girl LLC) offers compounded semaglutide and tirzepatide in injectable, microdose, and oral dissolving tablet (ODT) formats.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRavia Health +17
28
45
Dose & formulationGood Girl Rx +35
88
53
Clinical oversightRavia Health +6
81
87
Labs & monitoringRavia Health +13
52
65
FulfillmentGood Girl Rx +27
85
58
Contract termsEven
41
41
Good Girl Rx · left barRavia Health · right bar

The numbers

MetricGood Girl RxRavia Health
WeighScore62.1/10059.2/100
GradeCC
Scorecard rank#277#347
Semaglutide$79/mo (microdose tier, 12-month plan, compounded)Not disclosed
Tirzepatide$139/mo (microdose tier, 12-month plan, compounded)Not disclosed
CoverageAll 50 states1 state
Brand-name accessYesYes
Oral / sublingualYesInjection only
Good Girl Rx

Graded #277 · C

Strengths

  • LegitScript certified
  • Multiple formats — injectable, microdose, and ODT pills — for both semaglutide and tirzepatide
  • Dispensed by licensed 503A or 503B pharmacies
  • Limited brand-name options available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • Named legal entity with a Nashville address

Where it loses points

  • The advertised rates require twelve months paid up front; billed month to month the same products are $184 and $244, roughly 2.3 times as much
  • Every plan is prepaid — the discount exists only on the 3-, 6- and 12-month terms
  • The priced products are microdoses, not labelled therapeutic doses; the standard compounded semaglutide is $134/mo and also needs a year up front
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Ravia Health

Graded #347 · C

Strengths

  • Integrative psychiatry model combines GLP-1 weight-loss with mental health and metabolic care under one board-certified NP provider
  • Founded by Dr. Raashida Portier (DNP, PMHNP-BC, FNP-BC); named clinician with dual board certifications in psychiatry and family medicine
  • Membership-supported ongoing care from $49/month provides medication management structure with consistent follow-up
  • Labs and metabolic workup available as part of integrative psychiatry model; lab testing noted in weight-loss program
  • Weight-loss page claims nationwide availability via Lyv Health partnership for eligible patients

Where it loses points

  • GLP-1 medication pricing fully gated — not disclosed until consultation; compounded vs. brand status unclear on public pages
  • Primarily a psychiatric practice — weight loss is a secondary service, not the core offering or brand identity
  • Core services explicitly Florida-only; nationwide weight-loss claim relies on Lyv Health partnership with unverified state coverage
  • No LegitScript certification or third-party accreditation found on public pages
  • Small single-provider practice with no published outcomes data or external reviews available

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard